Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin Cell Rep
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma Future Oncol
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study Blood Cancer J
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia Cancer Cell Int
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party BONE MARROW TRANSPL
Global Shift in Alternative Splicing and Therapeutic Susceptibilities in Leukemia Driven by METTL3 Overexpression Blood Cancer Discov
Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function (May, 10.1055/s-0043-1768510, 2023) KLIN PADIATR
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer Mol Cancer